“New” Tekmira Emerges as HBV Frontrunner
Research - This is the first clinical step for “new Tekmira”. Announced last week, Tekmira is merging with OnCore Biopharma to focus on therapeutics for Hepatitis B.
Read nowSearch Results for gene therapy
V-Bottom’s Back, Gilead’s Biggest Overhang is Removed: Our Weekly Recap
Recap - We’re in the throes of yet another sharp “V-bottom” for the S&P 500 (SPX), a rapid drop followed by a rip-your-face off rally – the 10th occurrence … Continue Reading
Read now
Abraxane Inventor Puts Money to Work in Sorrento
Research - On Monday, Sorrento announced that Dr. Patrick Soon-Shiong made a $41 million investment in the company and now owns 19.9% of Sorrento.
Premium
Sorrento’s New Investor Isn’t JUST a Billionaire
Insights - Investor/entrepreneur Dr. Patrick Soon-Shiong is making a sizable investment in Sorrento Therapeutics (SRNE), in addition to forming a joint venture with the small company to develop … Continue Reading
Read now
Checkpoint Inhibitors: What are They and One Compelling Small-Cap Player
Research - Immune checkpoint regulators are again making headlines, this time at the American Society of Hematology, where they are demonstrating exciting early efficacy in hematological malignancies. … Continue Reading
Read now
Puma Biotech’s Delay Increases Headline Risk in 2016
Insights - Puma Biotech (PBYI) on Tuesday evening announced a significant, unexpected delay in its timeline for filing a New Drug Application with the FDA for lead … Continue Reading
Read now
All Hallow’s Eve but October Has Already Been Downright Spooky
Recap - Despite this asset class having just entered human testing, there’s significant excitement surrounding the therapeutic potential of blocking CD47 and the “DO NOT EAT” signal … Continue Reading
Read now